FindTrial
Sign In

Effectiveness of steroid injection with and without cryotherapy in the treatment of keloid scars

Comparing the effectiveness of intralesional injection of steroid in keloid treatment with and without cryotherapy: a randomized controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230124057201N2
Enrollment
32
Registered
2023-03-24
Start date
2023-04-03
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keloid. Acne keloid

Interventions

Intervention 1: Intervention group: Keloid lesions of this group will receive intralesional injection of triamcinolone acetonide (40mg/ml) with maximum dose of 20mg/ml for each lesion. injection will

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age between 18-65 years Patients who didn't have prior intralesional injection with steroid or verapamil More than two lesions are available

Exclusion criteria

Exclusion criteria: Pregnant patients or patients who are intended to get pregnant Lactation Underlying kidney or liver disease Hematologic disorder or bone marrow suppression Presence of systemic or local infection Keloid in the face area

Design outcomes

Primary

MeasureTime frame
Effectiveness of steroid will be assessed based on POSAS questionnaire. Timepoint: Month 0(baseline), month 3 and month 6. Method of measurement: POSAS(patient and observer scar assessment scale).—

Secondary

MeasureTime frame
Effectiveness of steroid with and without cryotherapy based on Fitzpatrick skin type. Timepoint: Month 0(baseline), month 3 and month 6. Method of measurement: Fitzpatrick skin type classification.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Zeinab Aryanian

Tehran University of Medical Sciences

z_aryanian@yahoo.com+98 21 5563 0553

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026